businesspress24.com - Spiracur Awarded Three-Year New Technology Contract by Novation for Advanced Wound Care Products and
 

Spiracur Awarded Three-Year New Technology Contract by Novation for Advanced Wound Care Products and Related Accessories

ID: 1066818

(firmenpresse) - SUNNYVALE, CA -- (Marketwire) -- 12/16/11 -- ., developer of a small, non-powered innovative negative pressure wound therapy (NPWT) device, today announced that it has been awarded a three-year new technology product supplier agreement by , LLC (Irving, TX), the healthcare industry's leading supply contracting company. Spiracur will supply non-powered advanced NPWT products and related accessories to VHA Inc., UHC, and Provista, LLC members.

The members Novation serves will have access to Spiracur's and supplies including the new which was recently introduced at the Fall Symposium on Advanced Wound Care (SAWC) in November 2011.

Clinical case studies and on-going research have reported significant data supporting the efficacy and safety of Spiracur's SNaP Wound Care System for the treatment of chronic lower extremity wounds. The SNaP System is the only non-powered NPWT device cleared by the U.S. Food & Drug Administration (FDA) to treat patients suffering from various wound types including chronic (such as diabetic, venous or pressure) and acute wounds, surgically closed incisions, flaps and grafts. The inventive design eliminates the electric or battery powered pump typically used to deliver NPWT, and the system is completely silent and lightweight, weighing only 2.2 ounces. As a result, the SNaP System can be worn under clothing, allowing patients to live their normal life without exposing their wound care treatment to the world.

"Partnering with Novation provides Spiracur access to VHA's 1,400 not-for-profit hospitals and 25,000+ non-acute healthcare organizations nationwide as well as 90 percent of the nation's nonprofit academic medical centers represented by UHC," said Dane Shackleford, vice president of sales for Spiracur Inc. "We are extremely pleased to enter into this agreement with such an esteemed organization and to provide members served by Novation with our innovative SNaP System and supplies, featuring the latest clinical advancements in wound therapy."





Founded in 1998, Novation is the leading health care supply contracting company for the more than 65,000 members of VHA Inc. and UHC, two national health care alliances, and Provista, LLC. Novation provides alliance members sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC and Provista members used Novation contracts to purchase nearly $40 billion in 2010. Novation recently earned the coveted Ethics Inside® Certification from the Ethisphere Institute, a leading international think tank dedicated to the research and promotion of best practices in corporate ethics and compliance, and is the only health care GPO to earn this distinction.

Spiracur Inc., headquartered in Sunnyvale, Calif., is a privately held medical device company focused on the development of innovative wound healing technologies. Spiracur was founded out of the Stanford Biodesign Innovation Program in 2007. Its first product, the SNaP Wound Care System, is the result of patient and clinician feedback that current negative pressure wound therapies were too cumbersome. The SNaP Wound Care System was cleared by the U.S. Food & Drug Administration (FDA) in August 2009 in a new therapy category defined as "non-powered" NPWT devices, and the company obtained CE Mark for the device in December 2010. For more information, please visit .

Spiracur, Spiracur logo, SNaP, SNaP & Design and Smart Negative Pressure are registered trademarks of Spiracur Inc.



Amy Cook
925.552.7893


Steve Van Dick
408.701.5300


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Genetic Technologies Appoints Dr. Mel Bridges as Chairman
MELA Sciences Announces Pricing of Underwritten Public Offering of Common Stock
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 16.12.2011 - 08:00 Uhr
Sprache: Deutsch
News-ID 1066818
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SUNNYVALE, CA


Phone:

Kategorie:

Medical Devices


Anmerkungen:


Diese Pressemitteilung wurde bisher 133 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Spiracur Awarded Three-Year New Technology Contract by Novation for Advanced Wound Care Products and Related Accessories
"
steht unter der journalistisch-redaktionellen Verantwortung von

Spiracur Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Spiracur Inc.



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 82


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.